Found 609 results
Filters: Keyword is Humans  [Clear All Filters]
2017
M Janjua B, Ivasyk I, Greenfield JP.  2017.  Vertebrobasilar Insufficiency Due to Distal Posterior Inferior Cerebellar Artery Compression in Chiari 1.5.. World Neurosurg. 104:1050.e1-1050.e6.
Perez K, Clancy TE, Mancias JD, Rosenthal MH, Wolpin BM.  2017.  When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.. J Clin Oncol. 35(5):485-489.
Liu Y, Pelham-Webb B, Di Giammartino DCampigli, Li J, Kim D, Kita K, Saiz N, Garg V, Doane A, Giannakakou P et al..  2017.  Widespread Mitotic Bookmarking by Histone Marks and Transcription Factors in Pluripotent Stem Cells.. Cell Rep. 19(7):1283-1293.
Zloza A, A Palucka K, Coussens LM, Gotwals PJ, Headley MB, Jaffee EM, Lund AW, Sharpe AH, Sznol M, Wainwright DA et al..  2017.  Workshop on challenges, insights, and future directions for mouse and humanized models in cancer immunology and immunotherapy: a report from the associated programs of the 2016 annual meeting for the Society for Immunotherapy of cancer.. J Immunother Cancer. 5(1):77.
Price EW, Carnazza KE, Carlin SD, Cho A, Edwards KJ, Sevak KK, Glaser JM, de Stanchina E, Janjigian YY, Lewis JS.  2017.  Zr-DFO-AMG102 Immuno-PET to Determine Local Hepatocyte Growth Factor Protein Levels in Tumors for Enhanced Patient Selection.. J Nucl Med. 58(9):1386-1394.
2016
Ahn D, Peñaloza H, Wang Z, Wickersham M, Parker D, Patel P, Koller A, Chen EI, Bueno SM, Uhlemann A-C et al..  2016.  Acquired resistance to innate immune clearance promotes ST258 pulmonary infection.. JCI Insight. 1(17):e89704.
O'Sullivan TE, Rapp M, Fan X, Weizman O-E, Bhardwaj P, Adams NM, Walzer T, Dannenberg AJ, Sun JC.  2016.  Adipose-Resident Group 1 Innate Lymphoid Cells Promote Obesity-Associated Insulin Resistance.. Immunity. 45(2):428-41.
Liang LW, Perez AR, Cangemi NA, Zhou Q, Iasonos A, Abu-Rustum N, Alektiar KM, Makker V.  2016.  An Assessment of Prognostic Factors, Adjuvant Treatment, and Outcomes of Stage IA Polyp-Limited Versus Endometrium-Limited Type II Endometrial Carcinoma.. Int J Gynecol Cancer. 26(3):497-504.
[Anonymous].  2016.  [Before retirement still quickly into the MVZ - that will not do!].. MMW Fortschr Med. 158(10):37.
Lewis BB, Carter RA, Pamer EG.  2016.  Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates.. Anaerobe. 41:32-36.
Zamolodchikov D, Berk-Rauch HE, Oren DA, Stor DS, Singh PK, Kawasaki M, Aso K, Strickland S, Ahn HJin.  2016.  Biochemical and structural analysis of the interaction between β-amyloid and fibrinogen.. Blood. 128(8):1144-51.
Weber B, Bersch-Ferreira ÂCristine, Torreglosa CRagne, Ross-Fernandes MBeatriz, da Silva JTereza, Galante APolo, Lara Ede Sousa, Costa RPerim, Soares RMarques, Cavalcanti ABiasi et al..  2016.  The Brazilian Cardioprotective Nutritional Program to reduce events and risk factors in secondary prevention for cardiovascular disease: study protocol (The BALANCE Program Trial).. Am Heart J. 171(1):73-81.e1-2.
Hurwitz ME, Sokhn J, Petrylak DP.  2016.  Cancer immunotherapy: new applications in urologic oncology.. Curr Opin Urol. 26(6):535-42.
Dick SA, Epelman S.  2016.  Chronic Heart Failure and Inflammation: What Do We Really Know? Circ Res. 119(1):159-76.
Bharani KL, Paller KA, Reber PJ, Weintraub S, Yanar J, Morrison RG.  2016.  Compensatory processing during rule-based category learning in older adults.. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 23(3):304-26.
Li B, Severson E, Pignon J-C, Zhao H, Li T, Novak J, Jiang P, Shen H, Aster JC, Rodig S et al..  2016.  Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.. Genome Biol. 17(1):174.
Sherman SI, Clary DO, Elisei R, Schlumberger MJ, Cohen EEW, Schöffski P, Wirth LJ, Mangeshkar M, Aftab DT, Brose MS.  2016.  Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.. Cancer. 122(24):3856-3864.
Hoban MD, Lumaquin D, Kuo CY, Romero Z, Long J, Ho M, Young CS, Mojadidi M, Fitz-Gibbon S, Cooper AR et al..  2016.  CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells.. Mol Ther. 24(9):1561-9.
Chau A, Markley JC, Juang J, Tsen LC.  2016.  Cytokines in the perinatal period - Part II.. Int J Obstet Anesth. 26:48-58.
Feelixge HSDe Silva, Stone D, Pietz HL, Roychoudhury P, Greninger AL, Schiffer JT, Aubert M, Jerome KR.  2016.  Detection of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy.. Antiviral Res. 126:90-8.
Singh G, Zhang J, Ma Y, Cerione RA, Antonyak MA.  2016.  The Different Conformational States of Tissue Transglutaminase Have Opposing Affects on Cell Viability.. J Biol Chem. 291(17):9119-32.
Galli LM, Zebarjadi N, Li L, Lingappa VR, Burrus LW.  2016.  Divergent effects of Porcupine and Wntless on WNT1 trafficking, secretion, and signaling.. Exp Cell Res. 347(1):171-83.
Guryanova OA, Shank K, Spitzer B, Luciani L, Koche RP, Garrett-Bakelman FE, Ganzel C, Durham BH, Mohanty A, Hoermann G et al..  2016.  DNMT3A mutations promote anthracycline resistance in acute myeloid leukemia via impaired nucleosome remodeling.. Nat Med. 22(12):1488-1495.
Goldberg AD, Tallman MS.  2016.  Down for the count in acute myeloid leukemia.. Blood. 128(18):2195-2197.
Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KMoore, Gregg A, Noggle S, Tessier-Lavigne M.  2016.  Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9.. Nature. 533(7601):125-9.